To the Editor:
We congratulate Auger et al for their study on takotsubo cardiomyopathy. 1 Auger et al 1 did not find any gender difference with regard to in hospital mortality, cardiovascular morbidity, and other hospitalization outcomes in their study. Vallabhajosyula et al 2 did a retrospective cohort study on patients with takotsubo cardiomyopathy in severe sepsis. They found a higher in-hospital mortality in males with takotsubo cardiomyopathy admitted with severe sepsis as compared to females with takotsubo cardiomyopathy. This contradicting result warrants more study to clarify any gender predilection of mortality in takotsubo cardiomyopathy. Auger et al 1 (Canadian study with 174 patients) showed almost 3 times higher recurrence rate (10.3% vs 4%) when compared with European multicenter GEIST (German Italian Stress Cardiomyopathy) Registry (749 patients). Is there any geographical predilection for takotsubo cardiomyopathy recurrence? It is difficult to conclude until data from various takotsubo cardiomyopathy-dedicated research bodies worldwide are integrated.
Also, a GEIST group studied patients with recurrent takotsubo cardiomyopathy compared with patients with a single episode of takotsubo cardiomyopathy at follow-up and found no significant difference for in-hospital mortality, cardiogenic shock, embolic events between the 2 groups with the exception of the higher incidence of pulmonary edema in the recurrent takotsubo cardiomyopathy group (13.3% vs 4.9%; P = 0.04). Did Auger et al 1 stratify outcomes to see the significance of takotsubo cardiomyopathy recurrence? For readers, it is important to know that the various takotsubo cardiomyopathy phenotypes (ie, apical form, midventricular form, basal form, and rare focal form) can change in up to 20% of recurrence cases. 3 Unfortunately, Auger et al 1 did not address this in their cohort with recurrent takotsubo cardiomyopathy. There is also reverse takotsubo cardiomyopathy, which compared with classical takotsubo cardiomyopathy, involves a younger age group and is associated with less decline in left ventricular ejection fraction but greater incidence of neurological disease. 4 In conclusion, in the last decade, takotsubo cardiomyopathy is getting more attention from research bodies internationally, and data is getting more consolidated, which may be helpful in answering many unsolved queries with regard to takotsubo cardiomyopathy and its complexities. 5 
